» Articles » PMID: 15385491

A New Cruzipain-mediated Pathway of Human Cell Invasion by Trypanosoma Cruzi Requires Trypomastigote Membranes

Overview
Journal Infect Immun
Date 2004 Sep 24
PMID 15385491
Citations 30
Authors
Affiliations
Soon will be listed here.
Abstract

The intracellular protozoan Trypanosoma cruzi causes Chagas' disease, a chronic illness associated with cardiomyopathy and digestive disorders. This pathogen invades mammalian cells by signaling them through multiple transduction pathways. We previously showed that cruzipain, the main cysteine protease of T. cruzi, promotes host cell invasion by activating kinin receptors. Here, we report a cruzipain-mediated invasion route that is not blocked by kinin receptor antagonists. By testing different strains of T. cruzi, we observed a correlation between the level of cruzipain secreted by trypomastigotes and the capacity of the pathogen to invade host cells. Consistent with a role for cruzipain, the cysteine protease inhibitor N-methylpiperazine-urea-Phe-homophenylalanine-vinylsulfone-benzene impaired the invasion of human smooth muscle cells by strains Dm28c and X10/6 but not by the G isolate. Cruzipain-rich supernatants of Dm28c trypomastigotes enhanced the infectivity of isolate G parasites twofold, an effect which was abolished by the cysteine protease inhibitor l-trans-epoxysuccinyl-leucylamido-(4-guanidino)butane and by thapsigargin, a drug that induces depletion of the intracellular Ca(2+) stores. The enhancement due to Dm28 supernatants was abolished upon cruzipain immunodepletion, and the activity was restored by purified cruzipain. In contrast, supernatants from isolate G trypomastigotes (with low levels of cruzipain) or supernatants from Dm28c epimastigotes or purified cruzipain alone did not enhance parasite invasion, indicating that the protease is required but not sufficient to engage this invasion pathway. We provide evidence that activation of this pathway requires cruzipain-mediated processing of a trypomastigote molecule associated with parasite-shed membranes. Our results couple cruzipain to host cell invasion through a kinin-independent route and further suggest that high-level cruzipain expression may contribute to parasite infectivity.

Citing Articles

Targeting Cysteine Proteases and their Inhibitors to Combat Trypanosomiasis.

Saha A, Pushpa , Moitra S, Basak D, Brahma S, Mondal D Curr Med Chem. 2023; 31(16):2135-2169.

PMID: 37340748 DOI: 10.2174/0929867330666230619160509.


Screening the Pathogen Box to Discover and Characterize New Cruzain and CatL Inhibitors.

do Valle Moreira T, Martins L, Diniz L, Bernardes T, de Oliveira R, Ferreira R Pathogens. 2023; 12(2).

PMID: 36839523 PMC: 9967275. DOI: 10.3390/pathogens12020251.


Antiparasitary and antiproliferative activities in vitro of a 1,2,4-oxadiazole derivative on Trypanosoma cruzi.

Rocha Y, Paula Magalhaes E, de Medeiros Chaves M, Marinho M, Melo de Oliveira V, Oliveira R Parasitol Res. 2022; 121(7):2141-2156.

PMID: 35610523 DOI: 10.1007/s00436-022-07554-z.


Differentiating Trypanosoma cruzi in a Host Mammalian Cell Imaged in Aqueous Liquid by Atmospheric Scanning Electron Microscopy.

Takagi Y, Sato M, Naya M, Sato C Microbiol Spectr. 2022; 10(1):e0141321.

PMID: 34985339 PMC: 8729778. DOI: 10.1128/spectrum.01413-21.


All Roads Lead to Cytosol: Multi-Strategic Approach to Invasion.

Ferri G, Edreira M Front Cell Infect Microbiol. 2021; 11:634793.

PMID: 33747982 PMC: 7973469. DOI: 10.3389/fcimb.2021.634793.


References
1.
Scharfstein J, Schmitz V, Morandi V, Capella M, Lima A, Morrot A . Host cell invasion by Trypanosoma cruzi is potentiated by activation of bradykinin B(2) receptors. J Exp Med. 2000; 192(9):1289-300. PMC: 2193362. DOI: 10.1084/jem.192.9.1289. View

2.
Caler E, Vaena de Avalos S, Haynes P, Andrews N, Burleigh B . Oligopeptidase B-dependent signaling mediates host cell invasion by Trypanosoma cruzi. EMBO J. 1998; 17(17):4975-86. PMC: 1170826. DOI: 10.1093/emboj/17.17.4975. View

3.
Lima A, dos Reis F, Serveau C, Lalmanach G, Juliano L, Menard R . Cysteine protease isoforms from Trypanosoma cruzi, cruzipain 2 and cruzain, present different substrate preference and susceptibility to inhibitors. Mol Biochem Parasitol. 2001; 114(1):41-52. DOI: 10.1016/s0166-6851(01)00236-5. View

4.
Monteiro A, Abrahamson M, Lima A, Vannier-Santos M, Scharfstein J . Identification, characterization and localization of chagasin, a tight-binding cysteine protease inhibitor in Trypanosoma cruzi. J Cell Sci. 2001; 114(Pt 21):3933-42. DOI: 10.1242/jcs.114.21.3933. View

5.
Grellier P, Vendeville S, Joyeau R, Bastos I, Drobecq H, Frappier F . Trypanosoma cruzi prolyl oligopeptidase Tc80 is involved in nonphagocytic mammalian cell invasion by trypomastigotes. J Biol Chem. 2001; 276(50):47078-86. DOI: 10.1074/jbc.M106017200. View